$LMAT
LEMAITRE VASCULAR INC Stock $lmat

$lmat Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923013314 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$50.12M	$47.08M	$39.56M
YoY Change	19.02%	18.99%	10.25%
Cost Of Revenue	$18.03M	$16.19M	$13.60M
YoY Change	26.09%	19.07%	12.54%
Gross Profit	$32.09M	$30.88M	$25.96M
YoY Change	15.38%	18.95%	9.09%
Gross Profit Margin	64.02%	65.6%	65.63%
Selling, General & Admin	$17.94M	$18.83M	$15.10M
YoY Change	15.19%	24.68%	16.08%
% of Gross Profit	55.91%	60.97%	58.17%
Research & Development	$4.516M	$3.875M	$2.932M
YoY Change	34.97%	32.16%	3.09%
% of Gross Profit	14.07%	12.55%	11.29%
Depreciation & Amortization	$2.326M	$2.351M	$2.373M
YoY Change	-4.83%	-0.93%	-9.57%
% of Gross Profit	7.25%	7.61%	9.14%
Operating Expenses	$22.45M	$22.70M	$18.03M
YoY Change	1.94%	25.9%	13.75%
Operating Profit	$9.632M	$8.179M	$7.928M
YoY Change	66.53%	3.17%	-0.21%
Interest Expense	$867.0K	$143.0K	$0.00
YoY Change			-100.0%
% of Operating Profit	9.0%	1.75%	0.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$10.32M	$8.017M	$7.996M
YoY Change	85.99%	0.26%	6.71%
Income Tax	$2.221M	$1.977M	$1.958M
% Of Pretax Income	21.52%	24.66%	24.49%
Net Earnings	$8.098M	$6.040M	$6.038M
YoY Change	130.38%	0.03%	1.84%
Net Earnings / Revenue	16.16%	12.83%	15.26%
Basic Earnings Per Share	$0.36	$0.27	$0.28
Diluted Earnings Per Share	$0.36	$0.27	$0.27
COMMON SHARES
Basic Shares Outstanding	22.16M	22.10M	21.94M
Diluted Shares Outstanding	22.45M	22.27M	22.10M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$90.18M	$81.01M	$70.88M
YoY Change	19.15%	14.28%	199.08%
Cash & Equivalents	$19.49M	$16.68M	$15.56M
Short-Term Investments	$70.69M	$64.33M	$55.32M
Other Short-Term Assets	$4.076M	$4.619M	$2.479M
YoY Change	0.17%	86.33%	-66.95%
Inventory	$53.83M	$53.78M	$46.66M
Prepaid Expenses
Receivables	$26.41M	$25.37M	$21.39M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$174.5M	$164.8M	$141.4M
YoY Change	17.51%	16.52%	55.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.02M	$34.77M	$16.68M
YoY Change	135.01%	108.41%	9.76%
Goodwill	$65.95M	$65.95M	$65.95M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$44.00M	$45.51M	$51.19M
YoY Change	-11.29%	-11.11%	-10.72%
Long-Term Investments
YoY Change
Other Assets	$5.012M	$3.876M	$556.0K
YoY Change	409.35%	597.12%	-49.91%
Total Long-Term Assets	$152.0M	$150.1M	$151.0M
YoY Change	0.69%	-0.62%	-3.62%
TOTAL ASSETS
Total Short-Term Assets	$174.5M	$164.8M	$141.4M
Total Long-Term Assets	$152.0M	$150.1M	$151.0M
Total Assets	$326.5M	$314.9M	$292.5M
YoY Change	9.03%	7.66%	18.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.519M	$3.371M	$2.194M
YoY Change	23.73%	53.65%	-14.33%
Accrued Expenses	$21.69M	$19.68M	$12.92M
YoY Change	27.49%	52.32%	-10.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.86M	$23.90M	$18.27M
YoY Change	10.47%	30.86%	-18.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$16.71M	$16.73M	$2.626M
YoY Change	567.72%	536.94%	-42.6%
Total Long-Term Liabilities	$16.71M	$16.73M	$2.626M
YoY Change	567.72%	536.94%	-42.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.86M	$23.90M	$18.27M
Total Long-Term Liabilities	$16.71M	$16.73M	$2.626M
Total Liabilities	$42.64M	$40.70M	$34.67M
YoY Change	3.02%	17.41%	-50.37%
SHAREHOLDERS EQUITY
Retained Earnings	$105.7M	$100.7M	$91.42M
YoY Change	14.65%	10.17%	23.17%
Common Stock	$197.2M	$192.2M	$183.5M
YoY Change	6.68%	4.74%	56.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$12.55M
YoY Change			7.35%
Treasury Stock Shares			$1.558M
Shareholders Equity	$283.8M	$274.2M	$257.8M
YoY Change
Total Liabilities & Shareholders Equity	$326.5M	$314.9M	$292.5M
YoY Change	9.03%	7.66%	18.23%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$8.098M	$6.040M	$6.038M
YoY Change	130.38%	0.03%	1.84%
Depreciation, Depletion And Amortization	$2.326M	$2.351M	$2.373M
YoY Change	-4.83%	-0.93%	-9.57%
Cash From Operating Activities	$11.90M	$2.279M	$4.711M
YoY Change	28.71%	-51.62%	-22.44%
INVESTING ACTIVITIES
Capital Expenditures	$2.803M	$2.130M	-$536.0K
YoY Change	-388.08%	-497.39%	-49.43%
Acquisitions		$270.0K	$0.00
YoY Change
Other Investing Activities	-$6.836M	-$834.0K	$0.00
YoY Change
Cash From Investing Activities	-$9.639M	-$2.964M	-$536.0K
YoY Change	890.65%	452.99%	-49.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$363.0K
YoY Change			-72.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	502.0K	-$1.825M	-$2.380M
YoY Change	-119.42%	-23.32%	-70.12%
NET CHANGE
Cash From Operating Activities	11.90M	$2.279M	$4.711M
Cash From Investing Activities	-9.639M	-$2.964M	-$536.0K
Cash From Financing Activities	502.0K	-$1.825M	-$2.380M
Net Change In Cash	2.766M	-$2.457M	$1.705M
YoY Change	-51.39%	-244.11%	-152.64%
FREE CASH FLOW
Cash From Operating Activities	$11.90M	$2.279M	$4.711M
Capital Expenditures	$2.803M	$2.130M	-$536.0K
Free Cash Flow	$9.100M	$149.0K	$5.247M
YoY Change	-10.97%	-97.16%	-26.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001158895
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16192000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	30883000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	25962000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10897000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7850000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7932000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7252000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3875000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2932000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	305000	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	23009000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	18034000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7874000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7928000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	568000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	108000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-425000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-40000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8017000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7996000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1977000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1958000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21935000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22274000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-3439000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2279000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22103000
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.140
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.125
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	252000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-300000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	207000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-889000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1189000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6499000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4849000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	254151000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1189000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	508000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	145000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1167000	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2743000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	257787000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	268201000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1446000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	172000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1290000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3099000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	274165000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2351000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2373000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1290000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1167000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	334000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	498000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-305000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-0	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-54000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	428000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	25000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-32000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	60000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3242000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1951000	usd
CY2023Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	3755000	usd
CY2022Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	1267000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1224000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1692000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2340000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4711000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2130000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	536000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	564000	usd
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	270000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2964000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-536000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1446000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	508000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	172000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	145000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3099000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2743000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1825000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2380000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-90000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2457000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1705000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19134000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13855000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16677000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15560000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47075000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39561000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	608000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	688000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	737000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	674000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	472000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	612000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	608000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	17695000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14929000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3940000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3662000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27233000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26688000	usd
CY2023Q1	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	4911000	usd
CY2022Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	4992000	usd
CY2023Q1	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	53779000	usd
CY2022Q4	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	50271000	usd
CY2023Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	1700000	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	1500000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	3100000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	141000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71394000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	25886000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45508000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	70854000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24327000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46527000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1559000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1516000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4489000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5772000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5440000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5041000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4764000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4378000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	580000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	525000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	162000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	163000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	742000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1290000	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0495	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0490	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2184000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2860000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2753000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2532000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2423000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2390000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4585000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3222000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	16505000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7713000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10770000	usd
CY2023Q1	lmat	Accrued Purchases Current AccruedPurchasesCurrent	5222000	usd
CY2022Q4	lmat	Accrued Purchases Current AccruedPurchasesCurrent	3748000	usd
CY2023Q1	lmat	Accrued Expenses Current AccruedExpensesCurrent	3839000	usd
CY2022Q4	lmat	Accrued Expenses Current AccruedExpensesCurrent	4640000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	380000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	449000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	164000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	108000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	302000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	252000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17620000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19967000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1167000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59000
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	32000
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1463000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1354000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	628000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	636000	usd
CY2023Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	187000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	177000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2278000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2167000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47075000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	39561000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1290000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1167000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21935000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21935000
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	163000
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	168000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22274000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22103000
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	320000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	430000
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	271000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	731000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1339000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1492000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-20000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1359000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1506000	usd

Files In Submission

Name	View Source	Status
0001437749-23-013314-index-headers.html	Edgar Link	pending
0001437749-23-013314-index.html	Edgar Link	pending
0001437749-23-013314.txt	Edgar Link	pending
0001437749-23-013314-xbrl.zip	Edgar Link	pending
ex_511463.htm	Edgar Link	pending
ex_511464.htm	Edgar Link	pending
ex_511465.htm	Edgar Link	pending
ex_511466.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lmat-20230331.xsd	Edgar Link	pending
lmat20230331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
lmat-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lmat-20230331_pre.xml	Edgar Link	unprocessable
lmat-20230331_lab.xml	Edgar Link	unprocessable
lmat-20230331_def.xml	Edgar Link	unprocessable
lmat20230331_10q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMAT
LEMAITRE VASCULAR INC Stock $lmat

2023 Q2 Form 10-Q Financial Statement

#000143774923013314 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT LEMAITRE VASCULAR INC Stock $lmat

2023 Q2 Form 10-Q Financial Statement

#000143774923013314 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT
LEMAITRE VASCULAR INC Stock $lmat